Merck & Co. Stock News

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces First-Quarter 2026 Dividend.

Merck stock jumped Tuesday on a surprise win for its drug, sotatercept, in patients with pulmonary hypertension.

RAHWAY, N.J.--(BUSINESS WIRE)--Merck's WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With CpcPH due to HFpEF.

Merck presents a bullish investment case with strong valuation, improving grades, and a well-supported, growing dividend. MRK's technical setup is positive: price trades above its 30-week EMA, momentum indicators are bullish, and volume shows institutional accumulation. Since its May low, the company has outperformed the S&P 500, with relative strength now trending higher and above its 30-week ...

Merck & Co., Inc. ( MRK ) M&A Call November 17, 2025 8:00 AM EST Company Participants Peter Dannenbaum - Vice President of Investor Relations Robert Davis - Chairman, President & CEO Dean Li - Executive VP & President of Merck Research Laboratories Chirfi Guindo - Senior VP & Chief Marketing Officer of Human Health Caroline Litchfield - Executive VP & CFO Conference Call Participants Carter Gou...

Merck said on Monday it expects a non-risk adjusted commercial opportunity in excess of $5 billion from Cidara Therapeutics' experimental flu drug.

This is my latest article, where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Dividend growth picked up from companies in the first half of November, with 6 companies announcing 10%+ increases, including ADP, Roper Technologies, Atmos, and Snap-on. Other notable companies expecting dividend hikes include Motorola Solutions, McCorm...

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cidara Therapeutics, Inc. (NasdaqCM: CDTX) to Merck & Co., Inc. (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Cidara will receive $221.50 in cash for each share of Cidar...